MARKETS
Analyst Actions

This Insmed Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday

Oct 12, 2026 · 09:03 AM ET· updated 2h ago
This Insmed Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday

Analysts downgraded UWMC, ACT, ROIV, INSM; ACT’s target fell to $44.

Share
Why It Matters

Some experts changed their minds and said these stocks look less attractive now. When smart people start doubting a company, it's worth asking what they learned.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.